News

The FDA had rejected the companies’ initial application in 2023, requesting additional data after the pharma firms reported ...
SOLASTA Bio has appointed three senior business and industry experts to support the company’s UK and US growth.
"Manufacturing these cutting-edge products inherently requires a workforce with enhanced knowledge and skills." ...
Find out how you can mitigate risks when expanding your biotech business internationally in the current tariff and trade ...
Rakovina Therapeutics is now ranked among the top 10 undervalued stocks in the Biotechnology industry on the Toronto Stock Exchange or TSX Venture Exchange. A stock is considered undervalued if it ...
MINSK, 19 April (BelTA) – Development prospects for the biotechnology industry were high on the agenda of a meeting in the Council of Ministers, BelTA learned from the government press service.
From a talent perspective, the pharma and biotech industry is highly competitive, according to William Holodnak, the CEO and founder of life sciences recruitment firm Occam. He noted that clients ...
Penny stocks are notoriously volatile, and so is the biotech industry. Put the two together and you have a recipe for headlines. But if you’re looking for an industry of possibilities ...
The expansion has been planned since 2023 as part of a long-term strategy to grow GemPharmatech’s U.S. business, a company spokesperson told Fierce Biotech ... within the industry that while ...
The Chinese biotech industry has grown rapidly to become a major hub of research. However, as US-China trade relations continue to deteriorate, Ben Hargreaves asks whether this could stunt ...
The biotech industry experienced heady highs in early 2021, but has since suffered from a tight financial climate that has brought bankruptcies and widespread redundancies. Ben Hargreaves examines ...